RxDoctor Payments Data

Christina Collins, MD

Internal Medicine · Columbus, MSNPI 1760692917

Payments from drug & device makers

$897in general payments, 2019–2025

Across 53 payments — averaging $16.93 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Amgen$219
  • Lilly USA, LLC$155
  • Johnson & Johnson$89
  • Boehringer Ingelheim$75
  • Pfizer$71
  • Dexcom, Inc.$55
  • plus $234 from 8 others

What the payments were for

  • Food & beverage$897100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$897 in reported general payments places this provider in the 60th percentile of 846 internal medicine providers in Mississippi.

See all internal medicine providers in Mississippi

Medicare billing

Part B allowed, 2024
$113,738
Medicare patients
304
Services billed
1,974

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide36$46,670
JanuviaSitagliptin Phosphate46$35,330
JardianceEmpagliflozin14$20,621
MounjaroTirzepatide13$11,351
RybelsusSemaglutide11$10,295
Tresiba Flextouch U-100Insulin Degludec26$5,220
SymbicortBudesonide/Formoterol Fumarate17$4,032
Lantus SolostarInsulin Glargine,hum.Rec.Anlog16$2,848
Montelukast Sodium88$2,564
Novolog Mix 70-30 FlexpenInsulin Aspart Prot/Insuln Asp14$2,090
Potassium Chloride62$1,448
Levothyroxine Sodium163$1,300
Rosuvastatin Calcium95$1,155
Novolin NInsulin Nph Human Isophane12$1,135
Atorvastatin Calcium121$761

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
MerckJanuvia$39$35,33046 claims
Boehringer IngelheimJardiance$75$20,62114 claims
Lilly USA, LLCMounjaro$155$11,35113 claims
AstraZenecaSymbicort$41$4,03217 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 846 internal medicine providers in Mississippi.

Other internal medicine in Columbus

See the full list for Mississippi

Where these figures come from

Is this you, or does something look wrong? →